These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8252043)

  • 1. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects.
    Goldberg YP; Kremer B; Andrew SE; Theilmann J; Graham RK; Squitieri F; Telenius H; Adam S; Sajoo A; Starr E
    Nat Genet; 1993 Oct; 5(2):174-9. PubMed ID: 8252043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
    Semaka A; Creighton S; Warby S; Hayden MR
    Clin Genet; 2006 Oct; 70(4):283-94. PubMed ID: 16965319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases.
    Goldberg YP; Andrew SE; Theilmann J; Kremer B; Squitieri F; Telenius H; Brown JD; Hayden MR
    J Med Genet; 1993 Dec; 30(12):987-90. PubMed ID: 8133509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
    Snell RG; MacMillan JC; Cheadle JP; Fenton I; Lazarou LP; Davies P; MacDonald ME; Gusella JF; Harper PS; Shaw DJ
    Nat Genet; 1993 Aug; 4(4):393-7. PubMed ID: 8401588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular diagnosis of Huntington's disease: an analysis of two large families].
    Zeng Y; Chen M; Mao Y
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):689-93, 711-2. PubMed ID: 8697093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.
    Myers RH; MacDonald ME; Koroshetz WJ; Duyao MP; Ambrose CM; Taylor SA; Barnes G; Srinidhi J; Lin CS; Whaley WL
    Nat Genet; 1993 Oct; 5(2):168-73. PubMed ID: 8252042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
    Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
    J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
    Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
    Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
    Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
    Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer simulation of expansions of DNA triplet repeats in the fragile X syndrome and Huntington's disease.
    Bat O; Kimmel M; Axelrod DE
    J Theor Biol; 1997 Sep; 188(1):53-67. PubMed ID: 9299309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unstable triplet repeat sequences: a source of cancer mutations?
    Panzer S; Kuhl DP; Caskey CT
    Stem Cells; 1995 Mar; 13(2):146-57. PubMed ID: 7787780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's Disease-like 2 (HDL2) in North America and Japan.
    Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
    Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
    Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
    Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trinucleotide repeat length instability and age of onset in Huntington's disease.
    Duyao M; Ambrose C; Myers R; Novelletto A; Persichetti F; Frontali M; Folstein S; Ross C; Franz M; Abbott M
    Nat Genet; 1993 Aug; 4(4):387-92. PubMed ID: 8401587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics of Huntington's disease].
    Goto J; Masuda N; Watanabe M; Kanazawa I
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic diseases and unstable expansions of trinucleotide repeats].
    Mandel JL
    Rev Prat; 1997 Jan; 47(2):155-61. PubMed ID: 9157513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trinucleotide repeat expansions and human genetic disease.
    Bates G; Lehrach H
    Bioessays; 1994 Apr; 16(4):277-84. PubMed ID: 8031305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal gene product identified in Huntington's disease lymphocytes and brain.
    Ide K; Nukina N; Masuda N; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 1995 Apr; 209(3):1119-25. PubMed ID: 7733967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.